Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation

NCT01962415 is registered in ClinicalTrials.gov with Paul Szabolcs as lead sponsor.

NCT NCT01962415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01962415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation
Lead sponsor
Paul Szabolcs
Phase
Phase 2
Overall status
Recruiting
Start date
February 4, 2014
Completion date
November 30, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bone marrow failure syndromes, hereditary anemias, inflammatory conditions, inherited metabolic disorders (imd), juvenile rheumatoid arthritis (jra), primary immunodeficiency (pid), systemic juvenile idiopathic arthritis (sjia)